Stockhub

PCI Biotech Holding ASA: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

  • curprev 03:5103:51, 19 August 2022 >Nick 892 bytes +892 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical st..."
Retrieved from "https://stockhub.co/research/PCI_Biotech_Holding_ASA"